Paper9727491
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.
Luo X and 4 others. Cell, 1998. Cited by 2,984 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Papers, record 9727491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9727491
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Carrier Proteins | Major topic |
| Caspases | Major topic |
| Cytochrome c Group | Major topic |
| Mitochondria, Liver | Major topic |
| Receptors, Cell Surface | Major topic |
| fas Receptor | Major topic |
| Amino Acid Sequence | |
| Animals | |
| BH3 Interacting Domain Death Agonist Protein | |
| Caspase 8 | |
| Caspase 9 | |
| Cysteine Endopeptidases | |
| HeLa Cells | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Proto-Oncogene Proteins c-bcl-2 | |
| Sequence Analysis | |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01GM-57158 | NIGMS NIH HHS | United States | R01GM057158 | PubMed and NIH |
Source NIH RePORTER
Cited by1,036
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,984 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,943,210 | Sophocarpine Inhibits Proliferation and Triggers Apoptosis in Breast Cancer Cells by Modulating the miR-21/PTEN/AKT and ERK1/2 Signaling Networks. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943210 | PubMed |
| 42,625,648 | Mitochondrial dysfunction in intracerebral hemorrhage: molecular mechanisms and pathological consequences. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/42625648 | PubMed |
| 42,598,472 | Synthesis and Biological Evaluation of Thiophene-Bridged Indole-Artesunate Hybrids as Selective Anticancer Agents. | ACS Omega | 2026 | https://conductscience.org/library/papers/42598472 | PubMed |
| 42,491,221 | Acupuncture-induced HSP70 upregulation in neuroprotection: mitochondrial and anti-apoptotic mechanisms. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42491221 | PubMed |
| 42,426,885 | Insights into programmed cell death from multiple imaging modalities. | J Transl Med | 2026 | https://conductscience.org/library/papers/42426885 | PubMed |
| 42,352,060 | Cannabigerol and Cannabichromene Induce Lung Cancer Cell Death and Apoptosis-Contribution of PPARα to Cannabigerol Effects. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42352060 | PubMed |
| 42,336,976 | Brusatol enhances the chemotherapy efficacy of Cisplatin and Gemcitabine in KKU-100 cholangiocarcinoma cells through ROS-mediated apoptosis. | Sci Rep | 2026 | https://conductscience.org/library/papers/42336976 | PubMed |
| 42,257,976 | Targeting programmed cell death: a novel therapeutic paradigm for cancer based on mode-of-death classification. | Apoptosis | 2026 | https://conductscience.org/library/papers/42257976 | PubMed |
| 42,230,857 | Hydrogel soft tissue expander for gingiva-periosteal expansion: a narrative literature review. | Maxillofac Plast Reconstr Surg | 2026 | https://conductscience.org/library/papers/42230857 | PubMed |
| 42,183,285 | Grape seed proanthocyanidins supplementation attenuates diquat-induced intestinal barrier damage in weaned pigs. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183285 | PubMed |
| 42,092,049 | Comparative insights into the apoptosome, inflammasomes and PIDDosome. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/42092049 | PubMed |
| 42,084,012 | A century of cell death research. | J Cell Sci | 2026 | https://conductscience.org/library/papers/42084012 | PubMed |
| 41,897,433 | THC and CBD Induce Heme Oxygenase-1-Dependent Cell Death and Trigger Mitochondrial Dysfunction in Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41897433 | PubMed |
| 41,839,827 | Nanoparticles-based phototherapy systems: molecular mechanisms and clinical applications. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41839827 | PubMed |
| 41,803,899 | Low-dose radiotherapy remodels the tumor immune microenvironment via the cGAS-STING pathway: mechanisms, challenges, and combination therapy strategies. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41803899 | PubMed |
| 41,714,805 | What does BCL-2 do? From new molecular insights to the clinical implications. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/41714805 | PubMed |
| 41,479,411 | Modulation of host cell pathways by Coxiella burnetii Dot/Icm effectors. | mLife | 2025 | https://conductscience.org/library/papers/41479411 | PubMed |
| 41,465,548 | Hypoxic Small Extracellular Vesicle Preconditioning of AC16 Cardiomyocytes Increase Caspase-3 and Caspase-8 Activity During Hypoxia. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465548 | PubMed |
| 41,419,664 | Stochasticity contributes to explaining minority and majority MOMP during apoptosis. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41419664 | PubMed |
| 41,381,861 | cFLIP suppresses caspase-1- and MLKL-independent perinatal lethality driven by auto-processing impaired caspase-8 D387A. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/41381861 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BID | 637 | Swiss-Prot's references | https://conductscience.org/library/genes/637 | NCBI Gene |
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CASP1 | 834 | PubTator's text mining | https://conductscience.org/library/genes/834 | NCBI Gene |
| CASP8 | 841 | PubTator's text mining | https://conductscience.org/library/genes/841 | NCBI Gene |
| CASP9 | 842 | PubTator's text mining | https://conductscience.org/library/genes/842 | NCBI Gene |
| CYCS | 54,205 | PubTator's text mining | https://conductscience.org/library/genes/54205 | NCBI Gene |
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
| GZMB | 3,002 | PubTator's text mining | https://conductscience.org/library/genes/3002 | NCBI Gene |
| HRK | 8,739 | PubTator's text mining | https://conductscience.org/library/genes/8739 | NCBI Gene |
| TNF | 7,124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9727491
GET https://conductscience.org/api/papers/v1/9727491/cited_by?page=2